Page last updated: 2024-08-24

ranolazine and Tachycardia, Supraventricular

ranolazine has been researched along with Tachycardia, Supraventricular in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belardinelli, L; Shryock, JC; Song, Y2
Eckhardt, LL; January, CT; Teelin, TC1

Other Studies

3 other study(ies) available for ranolazine and Tachycardia, Supraventricular

ArticleYear
A slowly inactivating sodium current contributes to spontaneous diastolic depolarization of atrial myocytes.
    American journal of physiology. Heart and circulatory physiology, 2009, Volume: 297, Issue:4

    Topics: Acetanilides; Action Potentials; Animals; Atrial Function; Cnidarian Venoms; Diastole; Female; Guinea Pigs; Heart Atria; Hydrogen Peroxide; Kinetics; Male; Myocytes, Cardiac; Patch-Clamp Techniques; Piperazines; Ranolazine; Sodium; Sodium Channel Blockers; Sodium Channels; Tachycardia, Supraventricular; Tetrodotoxin

2009
An increase of late sodium current induces delayed afterdepolarizations and sustained triggered activity in atrial myocytes.
    American journal of physiology. Heart and circulatory physiology, 2008, Volume: 294, Issue:5

    Topics: Acetanilides; Action Potentials; Animals; Anti-Arrhythmia Agents; Calcium; Cardiotonic Agents; Chelating Agents; Cnidarian Venoms; Egtazic Acid; Guinea Pigs; Heart Atria; Heart Conduction System; Myocytes, Cardiac; Patch-Clamp Techniques; Piperazines; Ranolazine; Ryanodine; Ryanodine Receptor Calcium Release Channel; Sodium; Sodium Channel Blockers; Sodium Channels; Sodium-Calcium Exchanger; Tachycardia, Supraventricular; Tetrodotoxin; Thiourea; Time Factors; Up-Regulation

2008
Is ranolazine an antiarrhythmic drug?
    American journal of physiology. Heart and circulatory physiology, 2008, Volume: 294, Issue:5

    Topics: Acetanilides; Action Potentials; Animals; Anti-Arrhythmia Agents; Calcium; Cardiotonic Agents; Chelating Agents; Heart Atria; Heart Conduction System; Humans; Myocytes, Cardiac; Piperazines; Ranolazine; Sodium; Sodium Channel Blockers; Sodium Channels; Tachycardia, Supraventricular; Time Factors; Up-Regulation

2008